this topic is incredibly divisive which is why i tend not

New Post Public Reply Private Reply Replies (3) Message Board
4kids petemantx #43331
416
this topic is incredibly divisive which is why i tend not to engage rather just post out the data and let folks make a determination .. some take the time and research just just how *fungible* the OTC was for years .. i'll lay odds that any *aware* OTC mgmt team today would not come public via a R/M .. rather do so via an S-1 registration due to how *handled* re: reporting by NR (non retail)

to keep it simple my focus isn't on *legal shorting* .. i've noted numerous times that the entity working the cycle of money (UP/DOWN) on IPIX had issues since their *imo* illegally orchestrated take up of December 2014 .. just shy of $5.00

imo it took that entity months to *SET UP* the events of late summer 2015 for that round of take down .. fortunately mgmt responded in a manner that could not be misinterpreted .. but it didn't change Non Retails' *goal*

what i note is the liquidity (volume) of the cycles in play .. and what i've noted for months on end .. is NR is struggling .. make no mistake (and i don't say this to scare anyone) when there is no liquidity besides the bogus kind created by NR and their *crew* .. the only option left to NR is to relentlessly compress the PPS because they need *volume* that isn't of their own making (wash traded)

which has been done consistently since early 2015 .. that is why each reset cycle UP is done at a lower PPS

but anyone can just observe *volume* and see how it has decreased in correlation with relentless PPS compression .. which doesn't work in NRs' favor

as i noted imo NR would have been able to *reset* the 52 week low of 63c (May 2017) .. far more quickly than Feb 22, 2018 .. except mgmt changed
out name/ticker/cusip in June which *imo* forced a change out on the legal
which had been approx 1.3M b4 being reduced to approx 800k .. which then
had to go back up to 1.2M (where it held for most of the last 9 months) ..

imo this effort is being done for a few reasons .. there will always be investors who can't watch an *erosion* of 20c .. 30c .. 40c .. 50c .. per share

some are now upside down 4.00 per share .. btw another tried and true NR tactic is to have some ambulance chaser on hedgies' speed dial trolling for a lead plaintiff for a CA .. anything to create FUD .. and garner *shares* out of shareholders with that *announcement*

the last round imo (as noted here) was done to target those with a CB in 1.50 to 2.50 price point

it is very clear to me this round is going for those in the 1.00 to 2.00 price point

after *volume* had been declining for the last year .. events of the last month had to show *volume* increasing .. which is why i look for what i perceive to be wash traded trades (daily tape of trades which makes up the *volume*) which are crystal clear when viewed

note the volume avgs today .. b4 today's *volume* .. the 10 day is lower than the 90 day (10 day is far easier to orchestrate than the 90 day)

3.20.2017 IPIX Volume 497,740
Volume (10 day Average) 203,568
Volume (90 day Average) 253,997


this is just after mgmt's change out for name/ticker/cusip

0.73Down -0.01 (-1.35 %)AS OF 3:59:12PM ET 06/20/2017
6.20.2017 IPIX Volume 188,080
Volume (10 day Average) 314,423
Volume (90 day Average) 268,572


this is after May 2017's 52 week low was reset

0.90375Up 0.05375 (6.32 %)AS OF 3:59:28PM ET 05/19/2017
5.19.2017 IPIX Volume 213,550
Volume (10 day Average) 140,183
Volume (90 day Average) 278,946


this was in September 2017

0.725Down -0.015 (-2.03 %)AS OF 3:59:50PM ET 09/20/2017

9.20.2017 IPIX Volume 78,683
Volume (10 day Average) 92,820
Volume (90 day Average) 225,032


and this was December 2017

0.71Down -0.0125 (-1.73 %)AS OF 3:51:36PM ET 12/20/2017
12.20.2017 IPIX Volume 273,110
Volume (10 day Average) 514,039
Volume (90 day Average) 205,158


again imo NR has a liquidity issue .. which is why i note they are UPSIDE DOWN

they all collude *imo* .. and besides crushing a stock for obvious reasons .. another *goal* as i've pointed out is to get the PPS to where *certain brokerage firms* only allow sells not buys .. 25c and 10c come to mind

the OTC .. while slowly being cleaned up .. remains mired in muck courtesy of multiple colluding entities .. OTC SURVIVORS are scarcer then hens' teeth

lastly this stat was also easily called again .. NR continues to struggle

20180320|IPIX|246249|0|497740|O 49.47%

4kids

At what point, if any, do the shorts say we have reset low enough? Anything to stop this constant SP attack prior to deal announcement or will excellent P top line give the SP a good kick in the rear? Right now looks like a few tough weeks staring us in the face.


.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 105

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 69

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 73

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 107

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 119

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 93

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 69

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Mauna Kea Technologies Advances AI Integration in Endomicroscopy

Updated Category News Views 512

Mauna Kea Technologies and its Innovative AI Patent Mauna Kea Technologies, the proud inventor of Cellvizio®, a revolutionary platform that blends probe and needle-based confocal laser endomicroscopy (p/nCLE), has taken a significant step forward in the realm of artificial intelligence in medical diagnostic procedures. Recently, the company announced the granting of a...

Continue Reading
Hot Chili Limited Secures Approval for La Verde Expansion Drilling

Updated Category News Views 168

Hot Chili Limited's Significant Progress at La Verde Hot Chili Limited (OTCQX: HHLKF) has obtained key regulatory approval to enhance the drill coverage of its La Verde copper-gold discovery. This exciting development comes as the company aims to broaden exploration activities in an area strategically important to its operations. Understanding the La Verde Project The La...

Continue Reading
Investors on High Alert as Lithium Faces Growing Demand Challenges

Updated Category News Views 261

The Lithium Debate: Rising Tensions at COP30 At the recent climate discussions, the dialogue took an unexpected turn, raising eyebrows among investors in various clean-tech sectors. For the first time in thirty years of United Nations climate negotiations, serious concerns emerged regarding the social and environmental risks associated with lithium mining, which is...

Continue Reading
Edible Garden Expands USDA Organic Herb Line in New Markets

Updated Category News Views 71

Introducing Edible Garden's Organic Product Line Edible Garden AG Incorporated has been making headlines as a leader in controlled environment agriculture (CEA). Recently, they launched their USDA Organic herb product line at Green’s Natural Foods and The Extra Supermarket, which is a significant step in their mission to provide sustainably grown and organic produce....

Continue Reading
Growth Surge: The Value of $100 Investment in Riot Platforms

Updated Category News Views 148

Understanding the Rise of Riot Platforms Investors seeking substantial growth often look to companies like Riot Platforms (NASDAQ: RIOT), which has demonstrated impressive performance over the past five years. With a remarkable annualized return of 46.95%, Riot has outpaced the market by over 34.28%. This consistent growth contributes to a current market capitalization of...

Continue Reading